Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Halozyme Therapeutics Raises FY2025 Adj EPS Guidance from $6.00-$6.40 to $6.10-$6.50 vs $6.16 Est; Raises FY2025 Sales Guidance from $1.275B-$1.355B to $1.300B-$1.375B vs $1.319B Est

Author: Benzinga Newsdesk | November 03, 2025 04:03pm

Posted In: HALO